Jim Simons Adaptive Biotechnologies Corp Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Renaissance Technologies LLC holds 169,400 shares of ADPT stock, worth $794,486. This represents 0.0% of its overall portfolio holdings.

Number of Shares

169,400

Previous 151,800 11.59%

Holding current value

$794,486

Previous $549,000 57.92%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.37 - $5.12 $59,312 - $90,112	17,600 Added 11.59%	169,400 $867,000
Q2 2024 Aug 09, 2024	BUY	$2.34 - $3.96 $232,167 - $392,899	99,217 Added 188.69%	151,800 $549,000
Q1 2024 May 13, 2024	BUY	$2.88 - $4.8 $151,439 - $252,398	52,583 New	52,583 $169,000
Q3 2023 Nov 14, 2023	SELL	$5.07 - $8.44 $1.46 Million - $2.42 Million	-287,300 Reduced 84.87%	51,200 $279,000
Q2 2023 Aug 11, 2023	SELL	$6.19 - $8.78 $343,545 - $487,289	-55,500 Reduced 14.09%	338,500 $2.27 Million
Q1 2023 May 12, 2023	SELL	$7.8 - $10.11 $170,040 - $220,398	-21,800 Reduced 5.24%	394,000 $3.48 Million
Q4 2022 Feb 13, 2023	SELL	$6.26 - $9.34 $262,920 - $392,280	-42,000 Reduced 9.17%	415,800 $3.18 Million
Q3 2022 Nov 14, 2022	SELL	$6.5 - $12.67 $186,550 - $363,629	-28,700 Reduced 5.9%	457,800 $3.26 Million
Q2 2022 Aug 12, 2022	BUY	$6.4 - $14.73 $197,760 - $455,157	30,900 Added 6.78%	486,500 $3.94 Million
Q1 2022 May 13, 2022	BUY	$10.12 - $28.9 $4.61 Million - $13.2 Million	455,600 New	455,600 $6.32 Million
Q2 2021 Aug 13, 2021	SELL	$32.22 - $44.59 $5.16 Million - $7.14 Million	-160,200 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$37.26 - $67.74 $5.97 Million - $10.9 Million	160,200 New	160,200 $6.45 Million

Others Institutions Holding ADPT

# of Institutions

201

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $670M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account